References
Berényi E, Sonkoly I, Kavai M, Szabolcsi M, Szegedi Gy (1977) Use of levamisole in Hodgkin's disease. (Letter). N Engl J Med 296:941
Golding H, Golding B, Jacobson R, Lomnitzer R, Koornhof HJ, Rabson AR (1976) In vitro reversal of cellular unresponsiveness induced by levamisole. Clin Exp Immunol 26:295
Holm G, Mellstedt H, Björkholm M, Johansson B, Killander D, Sundblad R, Söderberg G (1976) Lymphocyte abnormalities in untreated patients with Hodgkin's disease. Cancer 37:751
Kazura JW, Negendank W, Guerry D, Schreiber AD (1979) Human monocyte-lymphocyte interaction and its enhancement by levamisole. Clin Exp Immunol 35:258
Levo Y, Rotter V, Ramot B (1975) Restoration of cellular immune response by levamisole in patients with Hodgkin's disease. Biomedicine 23:198
Marx JL (1976) Cancer immunotherapy: Focus on the drug levamisole. Science 191:57
Ramot B, Biniaminov M, Shoham Ch, Rosenthal E (1976) Effect of levamisole on E-rosette-forming cells in vivo and in vitro in Hodgkin's disease. N Engl J Med 294:809
Verhaegen H, De Cree J, De Cock W, Verbruggen F (1977) Restoration by levamisole of low E-rosette forming cells in patients suffering from various diseases. Clin Exp Immunol 27:313
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Björkholm, M., Holm, G. & Mellstedt, H. Levamisole (LMS) in hodgkin's disease (HD). Cancer Immunol Immunother 8, 205–206 (1980). https://doi.org/10.1007/BF00205673
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00205673